Cornerstone Management’s Amgen AMGN Stock Holding History

Cornerstone Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-41	Closed	-$9.91K	–	56
2023 Q1	$9.91K	Hold	41	–	–	﹤0.01%	162
2022 Q4	$10.8K	Hold	41	–	–	﹤0.01%	155
2022 Q3	$9.24K	Hold	41	–	–	﹤0.01%	167
2022 Q2	$9.98K	Hold	41	–	–	﹤0.01%	169
2022 Q1	$9.91K	Hold	41	–	–	﹤0.01%	175
2021 Q4	$9.22K	Buy	+41	New	+$8.65K	﹤0.01%	155

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cornerstone Management's AMGN Position: Q2 2023 in Review

Cornerstone Management sold out of Amgen (AMGN) in Q2 2023, closing a stake of 41 shares — an estimated $9.91K sold.

Cornerstone Management first reported a position in AMGN in Q4 2021 and held it in 6 quarters. The position peaked at $10.8K in Q4 2022. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

Cornerstone Management reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
Cornerstone Management sold 41 Amgen shares in Q2 2023, an estimated $9.91K.
Cornerstone Management first reported a position in Amgen in Q4 2021 and held it in 6 quarters.
Cornerstone Management's Amgen position peaked at $10.8K in Q4 2022.
2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Cornerstone Management's 13F filing for Q2 2023, filed 10 Aug 2023.